TargetID has been an important springboard towards obtaining EUR 2.5 million in EU funds through Horizon Europe.
The data, tools and skills acquired through this project have helped us secure an ERA Chair grant, BioGeMT: Bioinformatics for Genomics in Malta, which will allow UM to have an expert and team in bioinformatics for 5 years. This in turn guarantees that the whole genome sequencing and transcriptomic data on 1000 samples acquired through TargetID will continue to deliver results that will be useful to science and society.
TargetID: Novel Drug Targets for Infectious Diseases is a University of Malta project funded through the #MCST COVID-19 R&D Fund 2020 jointly administered by the Malta Council for Science & Technology and Malta Enterprise.
